BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

349 related articles for article (PubMed ID: 15735720)

  • 1. Cucurbitacin Q: a selective STAT3 activation inhibitor with potent antitumor activity.
    Sun J; Blaskovich MA; Jove R; Livingston SK; Coppola D; Sebti SM
    Oncogene; 2005 May; 24(20):3236-45. PubMed ID: 15735720
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Discovery of JSI-124 (cucurbitacin I), a selective Janus kinase/signal transducer and activator of transcription 3 signaling pathway inhibitor with potent antitumor activity against human and murine cancer cells in mice.
    Blaskovich MA; Sun J; Cantor A; Turkson J; Jove R; Sebti SM
    Cancer Res; 2003 Mar; 63(6):1270-9. PubMed ID: 12649187
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reciprocal activation between PLK1 and Stat3 contributes to survival and proliferation of esophageal cancer cells.
    Zhang Y; Du XL; Wang CJ; Lin DC; Ruan X; Feng YB; Huo YQ; Peng H; Cui JL; Zhang TT; Wang YQ; Zhang H; Zhan QM; Wang MR
    Gastroenterology; 2012 Mar; 142(3):521-530.e3. PubMed ID: 22108192
    [TBL] [Abstract][Full Text] [Related]  

  • 4. HIV-1 protease inhibitor induces growth arrest and apoptosis of human prostate cancer LNCaP cells in vitro and in vivo in conjunction with blockade of androgen receptor STAT3 and AKT signaling.
    Yang Y; Ikezoe T; Takeuchi T; Adachi Y; Ohtsuki Y; Takeuchi S; Koeffler HP; Taguchi H
    Cancer Sci; 2005 Jul; 96(7):425-33. PubMed ID: 16053514
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Akt/protein kinase B signaling inhibitor-2, a selective small molecule inhibitor of Akt signaling with antitumor activity in cancer cells overexpressing Akt.
    Yang L; Dan HC; Sun M; Liu Q; Sun XM; Feldman RI; Hamilton AD; Polokoff M; Nicosia SV; Herlyn M; Sebti SM; Cheng JQ
    Cancer Res; 2004 Jul; 64(13):4394-9. PubMed ID: 15231645
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Concomitant inactivation of the epidermal growth factor receptor, phosphatidylinositol 3-kinase/Akt and Janus tyrosine kinase 2/signal transducer and activator of transcription 3 signalling pathways in cardiotoxin III-treated A549 cells.
    Su JC; Lin KL; Chien CM; Chuang PW; Chang LS; Lin SR
    Clin Exp Pharmacol Physiol; 2010 Aug; 37(8):833-40. PubMed ID: 20456425
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Activation of Stat3 by receptor tyrosine kinases and cytokines regulates survival in human non-small cell carcinoma cells.
    Song L; Turkson J; Karras JG; Jove R; Haura EB
    Oncogene; 2003 Jul; 22(27):4150-65. PubMed ID: 12833138
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Naphtho[1,2-b]furan-4,5-dione disrupts Janus kinase-2 and induces apoptosis in breast cancer MDA-MB-231 cells.
    Lin KL; Su JC; Chien CM; Tseng CH; Chen YL; Chang LS; Lin SR
    Toxicol In Vitro; 2010 Jun; 24(4):1158-67. PubMed ID: 20197088
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differentiation-inducing factor-1 (DIF-1) inhibits STAT3 activity involved in gastric cancer cell proliferation via MEK-ERK-dependent pathway.
    Kanai M; Konda Y; Nakajima T; Izumi Y; Kanda N; Nanakin A; Kubohara Y; Chiba T
    Oncogene; 2003 Jan; 22(4):548-54. PubMed ID: 12555068
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Constitutive activation of Stat3 in human prostate tumors and cell lines: direct inhibition of Stat3 signaling induces apoptosis of prostate cancer cells.
    Mora LB; Buettner R; Seigne J; Diaz J; Ahmad N; Garcia R; Bowman T; Falcone R; Fairclough R; Cantor A; Muro-Cacho C; Livingston S; Karras J; Pow-Sang J; Jove R
    Cancer Res; 2002 Nov; 62(22):6659-66. PubMed ID: 12438264
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Progestins induce transcriptional activation of signal transducer and activator of transcription 3 (Stat3) via a Jak- and Src-dependent mechanism in breast cancer cells.
    Proietti C; Salatino M; Rosemblit C; Carnevale R; Pecci A; Kornblihtt AR; Molinolo AA; Frahm I; Charreau EH; Schillaci R; Elizalde PV
    Mol Cell Biol; 2005 Jun; 25(12):4826-40. PubMed ID: 15923602
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Src kinases and not JAKs activate STATs during IL-3 induced myeloid cell proliferation.
    Chaturvedi P; Reddy MV; Reddy EP
    Oncogene; 1998 Apr; 16(13):1749-58. PubMed ID: 9582023
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Constitutive Stat3 activity up-regulates VEGF expression and tumor angiogenesis.
    Niu G; Wright KL; Huang M; Song L; Haura E; Turkson J; Zhang S; Wang T; Sinibaldi D; Coppola D; Heller R; Ellis LM; Karras J; Bromberg J; Pardoll D; Jove R; Yu H
    Oncogene; 2002 Mar; 21(13):2000-8. PubMed ID: 11960372
    [TBL] [Abstract][Full Text] [Related]  

  • 14. DC120, a novel and potent inhibitor of AKT kinase, induces tumor cell apoptosis and suppresses tumor growth.
    Deng R; Yang F; Chang SH; Tang J; Qin J; Feng GK; Ding K; Zhu XF
    Mol Pharmacol; 2012 Aug; 82(2):189-98. PubMed ID: 22553359
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Resistance to chemotherapy via Stat3-dependent overexpression of Bcl-2 in metastatic breast cancer cells.
    Real PJ; Sierra A; De Juan A; Segovia JC; Lopez-Vega JM; Fernandez-Luna JL
    Oncogene; 2002 Oct; 21(50):7611-8. PubMed ID: 12400004
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CCAAT/Enhancer binding protein delta (c/EBPdelta) regulation and expression in human mammary epithelial cells: I. "Loss of function" alterations in the c/EBPdelta growth inhibitory pathway in breast cancer cell lines.
    Sivko GS; DeWille JW
    J Cell Biochem; 2004 Nov; 93(4):830-43. PubMed ID: 15389879
    [TBL] [Abstract][Full Text] [Related]  

  • 17. TGF-beta inhibits IL-12-induced activation of Jak-STAT pathway in T lymphocytes.
    Bright JJ; Sriram S
    J Immunol; 1998 Aug; 161(4):1772-7. PubMed ID: 9712043
    [TBL] [Abstract][Full Text] [Related]  

  • 18. SD-1029 inhibits signal transducer and activator of transcription 3 nuclear translocation.
    Duan Z; Bradner JE; Greenberg E; Levine R; Foster R; Mahoney J; Seiden MV
    Clin Cancer Res; 2006 Nov; 12(22):6844-52. PubMed ID: 17121906
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cucurbitacin E, a tetracyclic triterpenes compound from Chinese medicine, inhibits tumor angiogenesis through VEGFR2-mediated Jak2-STAT3 signaling pathway.
    Dong Y; Lu B; Zhang X; Zhang J; Lai L; Li D; Wu Y; Song Y; Luo J; Pang X; Yi Z; Liu M
    Carcinogenesis; 2010 Dec; 31(12):2097-104. PubMed ID: 20732905
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of the Janus kinase (JAK)/signal transducters and activators of transcription (STAT) cascade in advanced glycation end-product-induced cellular mitogenesis in NRK-49F cells.
    Huang JS; Guh JY; Hung WC; Yang ML; Lai YH; Chen HC; Chuang LY
    Biochem J; 1999 Aug; 342 ( Pt 1)(Pt 1):231-8. PubMed ID: 10432321
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.